Prescription Drug Web Sites Could Be Healthier, Reports Keynote.SAN MATEO San Mateo (săn mətā`ō), city (1990 pop. 85,486), San Mateo co., W Calif., on San Francisco Bay; inc. 1894. It is a commercial and retail center with some high-technology manufacturing. San Mateo, Spanish for St. , Calif. -- Keynote Systems Keynote Systems, Inc. provides measurement and monitoring, service level and customer experience management services to customers to improve e-business performance by reducing costs, improving customer satisfaction and increasing profitability. (Nasdaq:KEYN): --Keynote Study Finds 20% of Remedy Seekers Frustrated frus·trate tr.v. frus·trat·ed, frus·trat·ing, frus·trates 1. a. To prevent from accomplishing a purpose or fulfilling a desire; thwart: with Drug Web Sites --Consumers Seeking More and Easier Access to Information --Study Examines Customer Experience Across 20 Leading Prescription Drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, Sites --Sites for Allergies, Depression and High Cholesterol Cholesterol, High Definition Cholesterol is a fatty substance found in animal tissue and is an important component to the human body. It is manufactured in the liver and carried throughout the body in the bloodstream. Evaluated for Success in Driving Consumers to Discuss Medication with their Doctors New competitive intelligence from Keynote Systems (Nasdaq:KEYN), The Internet Performance Authority(R), details the consumer's online experience while researching medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. and leading prescription drugs online -- and determines which sites and online features are most effective at driving patients to their doctors to discuss medications. The Keynote Best Practices Study of Pharmaceutical Web Sites is based on an examination of the online experience of 2,000 consumers as they interacted with 20 leading prescription drug Web sites. The study examined the leading prescription drug sites in the allergies, depression, high cholesterol, migraines and overactive bladder Overactive Bladder Definition Overactive bladder is the leakage of large amounts of urine at unexpected times, including during sleep. Description condition categories. Web sites for prescription drugs developed, produced or marketed by the following leading pharmaceutical companies were evaluated during the study: Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. (NYSE NYSE See: New York Stock Exchange :ABT ABT About ABT Abteilung (German: Department) ABT Abbott Laboratories (stock symbol) ABT American Ballet Theatre ABT Associação Brasileira de Telemarketing ABT Abort ABT Availability Based Tariff ), AstraZeneca (NYSE:AZN AZN Asian ), Eli Lilly Eli Lilly can refer to:
FRX Frequently Repeated Line FRX Fox Pro Report ), GlaxoSmithKline, Merck (NYSE:MRK MRK Merck & Company (stock symbol) MRK Mayer-Rokitansky-Kuster (anomaly) MRK Manual Remote Keying ), Ortho-McNeil Pharmaceutical Ortho-McNeil Pharmaceutical, inc. is a pharmaceutical manufacturer based in Raritan, New Jersey, and a subsidiary of Johnson & Johnson. The company was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. , Pfizer (NYSE:PFE 1. (text, editor) PFE - Programmer's File Editor. 2. (language) PFE - Portable Forth Environment. ), Schering-Plough (NYSE:SGP SGP Singapore (ISO Country code) SGP Schering-Plough (stock symbol) SGP Stability and Growth Pact SGP Southern Great Plains SGP Staatkundig Gereformeerde Partij SGP Speedway Grand Prix ), Valeant Pharmaceuticals (NYSE:VRX VRX Virtual Resources Executive VRX Voice Receive Mode ) and Wyeth Pharmaceuticals (NYSE:WYE). Consumers Seeking More Information, Easier Access to Information Across all conditions, the leading frustration among consumers researching conditions, medications, and condition-related lifestyle decisions is with the level of information available on the condition or drug, and the ease of accessing that information. Approximately 1 in 5 consumers (19%) expressed the opinion that the condition and drug information available on the Web was too basic -- and about 1 in 6 consumers (17%) said they had difficulty finding the information they were looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. . "Drug and condition Web sites have very unique challenges," said Lance Jones, associate director of competitive research for Keynote. "Consumers come to these sites with very different requirements and expectations than they do to other informational or commercial sites. Some are seeking very basic information and some are seeking very detailed information. However, it is quite clear that consumers in general are not completely satisfied with the quality of information available online and the ease of locating this information. The sites that excel in quickly providing consumers the information they want also excel in driving patients to their doctors to discuss the drug in question." The Keynote study measured more than 100 metrics for each site and captured both consumer attitudes and behaviors to determine which drug sites excelled in driving consumers to discuss the drug with their doctor and/or request a prescription.
Keynote Best Practices Study
Pharmaceutical Web Sites
Sites Most Successful at Driving Patients to Discuss Drug with their
Doctor
By Condition Category
----------------------------------------------------------------------
Condition Allergies Depression High Migraine Overactive
Cholesterol Bladder
----------------------------------------------------------------------
Leading Nasonex Lexapro Lipitor Zomig Ditropan
Web Site XL
----------------------------------------------------------------------
Keynote determined that the top drivers of consumer action were all related to information access, with access to the latest news and information, patient success stories and expert advice and articles having the greatest impact on driving consumers to talk to their doctors. Consumers self-reported that they are most interested in information on the triggers and causes of conditions, tips for coping with the condition and treatment options. Nasonex Top Site in the Allergies Category Nasonex was the clear leader in the Allergy condition category in terms of its Web site generating interest and intent for the consumer to discuss or request the medication with their doctors. Approximately 4 out of 10 (37%) of visitors to the Nasonex site reported they were likely to discuss the medication with their doctor. More than 3 in 10 (31%) visitors to the Nasonex site reported an intention to request or use the medication, a figure nearly twice as high as another major brand name allergy drug which recorded just 16% of visitors intending to request or use the drug. In terms of Web site features, consumers were most interested in information on tips for coping with allergies. Lexapro, Zoloft Top Sites in Depression Category Lexapro was the leading site in a highly competitive depression drug category with 35% of visitors to its site during the study reporting an interest in discussing the medication with their doctor, as compared to an industry-wide average of 33% expressing such an interest. 1 in 5 (20%) of visitors to the Lexapro site said they intended to request the medication from their doctors -- a figure similar to visitors to the Zoloft site (21%). Consumers self-reported that tips for coping with depression was the site feature they were most interested in; however, success stories of medication users had the greatest impact on actual likelihood to request the medication. Lipitor, Crestor Top Sites in Cholesterol Category Lipitor and Crestor were the most successful sites in the Cholesterol category, with 34% of visitors to the Lipitor site and 31% of visitors to the Crestor site reporting an interest in discussing the medication with their doctors. Crestor led in driving consumers to request a prescription for the medication from their doctors. The poorest performing site drove just 13% of visitors to request the medication, as compared to an industry-wide average of 23%. Consumers were most interested in finding information about diet and exercise to combat high cholesterol. Finding the latest news about high cholesterol had the highest correlation to success in consumers stating an intention to request a prescription for the drug from their doctor. Zomig Top Site in Migraine Category Zomig was the most successful site in the Migraine category driving 46% of visitors to report an intention to discuss the medication with their doctor -- and 38% to request a prescription from their doctor. These figures were significantly higher than the poorer performing sites in the condition category, with just 17% of visitors to a competitor Web site reporting an intention to request a competitive drug. Consumers visiting migraine Web sites were most interested in the triggers and causes of the condition. Ditropan XL Top Site in Overactive Bladder Category Ditropan XL was the most successful site in the overactive bladder category, driving 52% of visitors to the intention to discuss the medication with their doctors, the highest success rate across all conditions and Web sites studied. Visitors to the overactive bladder condition and drug sites were most interested in tips for coping with the condition. The following prescription drug Web sites were evaluated: --For Allergies: Allegra Al·leg·ra A trademark for the drug fexofenadine hydrochloride. fexofenadine hydrochloride Allegra, Telfast (UK) Pharmacologic class: Peripherally selective piperidine, selective histamine (Sanofi-aventis); Flonase(GlaxoSmithKline); Nasonex (Schering-Plough); and Zyrtec (Pfizer). --For Depression: Effexor XR (Wyeth Pharmaceuticals); Lexapro (Forest Pharmaceuticals); Paxil (GlaxoSmithKline); Prozac (Eli Lilly); and Zoloft (Pfizer). --For High Cholesterol: Crestor (AstraZeneca); Lipitor (Pfizer); TriCor (Abbott Laboratories); and Zocor (Merck). --For Migraines: Imitrex (GlaxoSmithKline); Maxalt (Merck); Migranal (Valeant Pharmaceuticals); Relpax (Pfizer); and Zomig (AstraZeneca). --For Overactive Bladder (OAB OAB Ordem dos Advogados do Brasil (Brazil) OAB Offline Address Book OAB Over-Active Bladder (urology) OAB Outlook Address Book (Microsoft) OAB Ocean Affairs Board ): Detrol LA (Pfizer); and Ditropan XL (Ortho-McNeil Pharmaceutical). For an abstract about Keynote's competitive intelligence study of prescription drug Web sites view: http://www.keynote.com/downloads/cem/Keynote_Pharma.pdf Customer Experience Management Keynote's customer experience management (CEM CEM contagious equine metritis. CEM selective medium chocolate agar made with Eugon agar and 5% horse blood; used to cultivate Taylorella equigenitalis. ) services offer both competitive intelligence studies and custom engagement services examining consumer attitudes and behavior on the Web. To learn more about Keynote's CEM solutions, visit: http://www.keynote.com/solutions/customer_experience_management.html About Keynote Founded in 1995, Keynote Systems (Nasdaq "KEYN") is the worldwide leader in services that improve online business performance and communications technologies. Keynote helps approximately 2,300 corporate customers and 11,000 individual subscribers become "the best of the best" online. The business premise supporting Keynote's mission is: "Online businesses can't manage what they don't measure." As an independent and trusted third-party, Keynote provides IT and marketing executives with unbiased benchmarking data, competitive analysis and operational metrics from the customer perspective. This data measures service levels and customer experience of Web sites, broadband services and mobile communications. Known as The Internet Performance Authority(R), Keynote manages a market-leading infrastructure of 1,600+ measurement computers and mobile devices in over 114 locations and 66+ metropolitan areas worldwide that assess service levels and a panel of over 160,000 consumers who participate in interactive Web site tests that assess user experience. These online user experience tests capture customer attitude and behavior to answer the critical "why" behind the "what." Keynote's geographically distributed measurement services, on-site monitoring appliances, competitive intelligence and custom studies ensure that its customers outpace out·pace tr.v. out·paced, out·pac·ing, out·pac·es To surpass or outdo (another), as in speed, growth, or performance. outpace Verb [-pacing, their competitors in online service levels and overall user experience. Keynote Systems, Inc. is headquartered in San Mateo, California San Mateo is a city in San Mateo County, California, in the San Francisco Bay Area. It is one of the larger suburbs on the San Francisco Peninsula, located between Burlingame to the north, Foster City to the East, and Belmont to the south. and can be reached at www.keynote.com or by phone in the U.S. at 650-403-2400. Keynote, The Internet Performance Authority and Perspective are registered trademarks of Keynote Systems, Inc. Other trademarks are the property of their respective owners. (C) 2006 Keynote Systems, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion